The Brain Tumor Biotech Center

The Brain Tumor Biotech Center is an interactive hub for scientists, clinicians and biotech companies in the neuro-oncology space to join forces and accelerate the delivery of novel drugs to patients living with brain tumors.

Neuro-oncology studies brain and spinal cord tumors, which are very life-threatening – the median life expectancy for a glioblastoma patient, for example, is 15 months after diagnosis. In most cases of brain cancer, treatment options are largely limited to surgery, radiation, and chemotherapy. Feinstein Institute researchers are working to discover new and better treatments for patients by designing and testing new drugs and drug delivery methods.

The Feinstein Institute for Medical Research hosted a ribbon cutting ceremony to celebrate
the opening of the Brain Tumor Biotech Center, which aims to accelerate treatments to
patients who suffer from brain tumors. During the event, a surprise announcement was
made that Voices Against Brain Cancer has made a donation of $1 million to the Center.


A progressive and capital-efficient model leveraging the world-class, Feinstein Institute expertise, the Brain Tumor Biotech Center represents an ideal partner for biotechnology companies as they complete preclinical testing, navigate the regulatory landscape, and execute on clinical development initiatives. As part of Northwell Health, the second largest integrated health system in the country, the Biotech Center is exceptionally placed to interface with the vast patient population and resources of the health system.

Experienced research scientists in the Biotech Center carry out in vitro and in vivo studies using
state-of-the-art tools and methodologies, including models for glioblastoma and medulloblastoma. In addition, the Center has experienced Medical Advisory and Investment Advisory Boards that offer both early and late-stage companies expertise in developing a product for market.

The Biotech Center also provides and coordinates the following on-site services:

John A. Boockvar, MD
Co-Director of the Brain Tumor Biotech Center
Phone: (212) 434-3900

Marc Symons, PhD
Co-Director of the Brain Tumor Biotech Center
Phone: (516) 562-1193